Teplizumab, a humanized monoclonal antibody to CD3 on T cells, is approved by the Food and Drug Administration to delay the onset of clinical type 1 diabetes (stage 3) in patients 8 years of age or ...
Share on Pinterest Experts say adults with type 1 diabetes are being misdiagnosed as having type 2 diabetes. SDI Productions/Getty Images Experts say many adults who develop type 1 diabetes are being ...